{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:01:44Z","timestamp":1773982904916,"version":"3.50.1"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260461"],"award-info":[{"award-number":["82260461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560487"],"award-info":[{"award-number":["82560487"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biochi.2026.01.007","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:30:05Z","timestamp":1768717805000},"page":"45-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SUMOylation and anticancer drug resistance"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4549-6386","authenticated-orcid":false,"given":"Hongwei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"7782","key":"10.1016\/j.biochi.2026.01.007_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.biochi.2026.01.007_bib3","article-title":"A 3D pancreatic cancer model with integrated optical sensors for noninvasive metabolism monitoring and drug screening","volume":"13","author":"Siciliano","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-024-07420-9","article-title":"Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death","volume":"208","author":"Kumar","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biochi.2026.01.007_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216742","article-title":"Targeting O-GlcNAcylation in cancer therapeutic resistance: the sugar Saga continues","volume":"588","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biochi.2026.01.007_bib6","first-page":"2021","article-title":"Posttranslational modifications in proteins: resources, tools and prediction methods","author":"Ramazi","year":"2021","journal-title":"Database"},{"issue":"17","key":"10.1016\/j.biochi.2026.01.007_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174402","article-title":"Therapeutic potential of targeting the SUMO pathway in cancer","volume":"13","author":"Kukkula","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.biochi.2026.01.007_bib8","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.4049\/jimmunol.157.10.4277","article-title":"Protection against Fas\/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin","volume":"157","author":"Okura","year":"1996","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.261","article-title":"Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2020","journal-title":"MedComm"},{"issue":"12","key":"10.1016\/j.biochi.2026.01.007_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrm3011","article-title":"The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition","volume":"11","author":"Gareau","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2026.01.007_bib11","article-title":"SUMO5, a novel Poly-SUMO isoform, regulates PML nuclear bodies","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2026.01.007_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ebiom.2018.12.031","article-title":"SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer","volume":"40","author":"Zubiete-Franco","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib13","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","article-title":"SUMO: from bench to bedside","volume":"100","author":"Chang","year":"2020","journal-title":"Physiol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.biochi.2026.01.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(00)00139-6","article-title":"Ubiquitin-like proteins: new wines in new bottles","volume":"248","author":"Yeh","year":"2000","journal-title":"Gene"},{"issue":"18","key":"10.1016\/j.biochi.2026.01.007_bib15","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1074\/jbc.273.18.11349","article-title":"Characterization of a second member of the sentrin family of ubiquitin-like proteins","volume":"273","author":"Kamitani","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biochi.2026.01.007_bib16","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1074\/jbc.275.9.6252","article-title":"Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2\/3","volume":"275","author":"Saitoh","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.biochi.2026.01.007_bib17","doi-asserted-by":"crossref","first-page":"35368","DOI":"10.1074\/jbc.M104214200","article-title":"Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1\/SAE2 and Ubc9","volume":"276","author":"Tatham","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molcel.2010.07.026","article-title":"Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif","volume":"39","author":"Matic","year":"2010","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2005.09.090","article-title":"A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation","volume":"337","author":"Owerbach","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2026.01.007_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1375.039","article-title":"Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene","volume":"1079","author":"Wang","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbrc.2009.02.060","article-title":"Characterization of a negative feedback network between SUMO4 expression and NFkappaB transcriptional activity","volume":"381","author":"Wang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3892\/ol.2020.12088","article-title":"SUMO4 small interfering RNA attenuates invasion and migration via the JAK2\/STAT3 pathway in non-small cell lung cancer cells","volume":"20","author":"Liang","year":"2020","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-5793(99)00367-1","article-title":"Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex","volume":"448","author":"Gong","year":"1999","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1097-2765(00)80133-1","article-title":"SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation","volume":"2","author":"Desterro","year":"1998","journal-title":"Mol. Cell"},{"issue":"18","key":"10.1016\/j.biochi.2026.01.007_bib25","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1093\/emboj\/16.18.5509","article-title":"The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p\/Uba2p heterodimer","volume":"16","author":"Johnson","year":"1997","journal-title":"Embo J."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1006\/bbrc.1998.9995","article-title":"In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2","volume":"254","author":"Okuma","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6929","key":"10.1016\/j.biochi.2026.01.007_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature01456","article-title":"Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8","volume":"422","author":"Walden","year":"2003","journal-title":"Nature"},{"issue":"45","key":"10.1016\/j.biochi.2026.01.007_bib28","doi-asserted-by":"crossref","first-page":"28198","DOI":"10.1074\/jbc.272.45.28198","article-title":"Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9","volume":"272","author":"Gong","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.biochi.2026.01.007_bib29","doi-asserted-by":"crossref","first-page":"21381","DOI":"10.1074\/jbc.272.34.21381","article-title":"Crystal structure of murine\/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system","volume":"272","author":"Tong","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib30","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1021\/bi026861x","article-title":"Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex","volume":"42","author":"Tatham","year":"2003","journal-title":"Biochemistry"},{"issue":"33","key":"10.1016\/j.biochi.2026.01.007_bib31","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1021\/bi0345283","article-title":"Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation","volume":"42","author":"Tatham","year":"2003","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/acs.biochem.8b01045","article-title":"UBC9 mutant reveals the impact of protein dynamics on substrate selectivity and SUMO chain linkages","volume":"58","author":"Wright","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.biochi.2026.01.007_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.dib.2016.02.015","article-title":"Observation of an E2 (Ubc9)-homodimer by crystallography","volume":"7","author":"Alontaga","year":"2016","journal-title":"Data Brief"},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(02)00630-X","article-title":"Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1","volume":"108","author":"Bernier-Villamor","year":"2002","journal-title":"Cell"},{"issue":"7616","key":"10.1016\/j.biochi.2026.01.007_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nature19071","article-title":"Capturing a substrate in an activated RING E3\/E2-SUMO complex","volume":"536","author":"Streich","year":"2016","journal-title":"Nature"},{"issue":"7042","key":"10.1016\/j.biochi.2026.01.007_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nature03588","article-title":"Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex","volume":"435","author":"Reverter","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.sbi.2007.08.018","article-title":"Taking it step by step: mechanistic insights from structural studies of ubiquitin\/ubiquitin-like protein modification pathways","volume":"17","author":"Capili","year":"2007","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"44","key":"10.1016\/j.biochi.2026.01.007_bib39","doi-asserted-by":"crossref","first-page":"41311","DOI":"10.1074\/jbc.M206741200","article-title":"PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription","volume":"277","author":"Nishida","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biochi.2026.01.007_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110662","article-title":"The activity of the EMT suppressor GRHL2 is regulated by SUMOylation","volume":"301","author":"Santjer","year":"2025","journal-title":"J. Biol. Chem"},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib41","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.ajpath.2012.01.026","article-title":"PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21","volume":"180","author":"Hoefer","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.biochi.2026.01.007_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neo.2016.06.005","article-title":"Corrigendum to \"PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer\" [Neoplasia 18 (2016) 282-293]","volume":"18","author":"Constanzo","year":"2016","journal-title":"Neoplasia"},{"issue":"19","key":"10.1016\/j.biochi.2026.01.007_bib43","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1074\/jbc.RA119.012338","article-title":"SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation","volume":"295","author":"Wu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002379","article-title":"Correction: DPPA2\/4 and SUMO E3 ligase PIAS4 opposingly regulate zygotic transcriptional program","volume":"21","author":"Yan","year":"2023","journal-title":"PLoS Biol."},{"issue":"23","key":"10.1016\/j.biochi.2026.01.007_bib45","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1101\/gad.944801","article-title":"PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies","volume":"15","author":"Sachdev","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.biochi.2026.01.007_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1685194","article-title":"SUMO E3 ligase PIASy mediates high glucose-induced activation of NF-\u03baB inflammatory signaling in rat mesangial cells","volume":"2017","author":"Huang","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"21","key":"10.1016\/j.biochi.2026.01.007_bib47","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1074\/jbc.M110.176693","article-title":"SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein","volume":"286","author":"Sun","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.biochi.2026.01.007_bib48","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1038\/onc.2010.297","article-title":"PIASy stimulates HIF1\u03b1 SUMOylation and negatively regulates HIF1\u03b1 activity in response to hypoxia","volume":"29","author":"Kang","year":"2010","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.biochi.2026.01.007_bib49","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/onc.2010.462","article-title":"SUMO E3 ligase activity of TRIM proteins","volume":"30","author":"Chu","year":"2011","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib50","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1074\/jbc.M110453200","article-title":"Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity","volume":"277","author":"Bies","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib51","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.molcel.2008.11.019","article-title":"PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop","volume":"32","author":"Lapi","year":"2008","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/cas.15618","article-title":"SUMOylation of TUFT1 is essential for gastric cancer progression through AKT\/mTOR signaling pathway activation","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biochi.2026.01.007_bib53","doi-asserted-by":"crossref","unstructured":"Pichler A, Gast A, Seeler JS, Dejean A, Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108\uff081\uff09\uff082002\uff09109-20.","DOI":"10.1016\/S0092-8674(01)00633-X"},{"key":"10.1016\/j.biochi.2026.01.007_bib54","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijbiomac.2022.11.312","article-title":"Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis","volume":"226","author":"You","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjad027","article-title":"Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma","volume":"15","author":"Qian","year":"2023","journal-title":"J. Mol. Cell Biol."},{"issue":"23","key":"10.1016\/j.biochi.2026.01.007_bib56","doi-asserted-by":"crossref","first-page":"16117","DOI":"10.1074\/jbc.M512757200","article-title":"Specification of SUMO1- and SUMO2-interacting motifs","volume":"281","author":"Hecker","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010504","article-title":"The SUMO E3 ligase activity of ORF45 determines KSHV lytic replication","volume":"18","author":"Liu","year":"2022","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007250","article-title":"SUMO E3 ligase Mms21 prevents spontaneous DNA damage induced genome rearrangements","volume":"14","author":"Liang","year":"2018","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107635","article-title":"Relocation of collapsed forks to the nuclear pore complex depends on sumoylation of DNA repair proteins and permits Rad51 Association","volume":"31","author":"Whalen","year":"2020","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.biochi.2026.01.007_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119524","article-title":"Cbx4 governs HIF-1\u03b1 to involve in Th9 cell differentiation promoting asthma by its SUMO E3 ligase activity","volume":"1870","author":"Huang","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0092-8674(03)00159-4","article-title":"The polycomb protein Pc2 is a SUMO E3","volume":"113","author":"Kagey","year":"2003","journal-title":"Cell"},{"issue":"24 Pt B","key":"10.1016\/j.biochi.2026.01.007_bib62","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.febslet.2015.11.028","article-title":"Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis","volume":"589","author":"Choi","year":"2015","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib63","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1128\/MCB.00825-08","article-title":"The CTCF insulator protein is posttranslationally modified by SUMO","volume":"29","author":"MacPherson","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"22","key":"10.1016\/j.biochi.2026.01.007_bib64","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1016\/j.febslet.2005.07.088","article-title":"Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo","volume":"579","author":"Weger","year":"2005","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.biochi.2026.01.007_bib65","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/s44318-024-00108-2","article-title":"Decitabine cytotoxicity is promoted by dCMP deaminase DCTD and mitigated by SUMO-dependent E3 ligase TOPORS","volume":"43","author":"Carnie","year":"2024","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib66","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/nar\/gkac009","article-title":"TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair","volume":"50","author":"Hariharasudhan","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.biochi.2026.01.007_bib67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/embor.2009.86","article-title":"MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission","volume":"10","author":"Braschi","year":"2009","journal-title":"EMBO Rep."},{"issue":"15","key":"10.1016\/j.biochi.2026.01.007_bib68","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.yexcr.2013.03.033","article-title":"The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes","volume":"319","author":"Harrison","year":"2013","journal-title":"Exp. Cell Res."},{"issue":"40","key":"10.1016\/j.biochi.2026.01.007_bib69","doi-asserted-by":"crossref","first-page":"14373","DOI":"10.1073\/pnas.0403498101","article-title":"Identification of a SUMO-binding motif that recognizes SUMO-modified proteins","volume":"101","author":"Song","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molcel.2018.07.027","article-title":"SUMO-mediated regulation of nuclear functions and signaling processes","volume":"71","author":"Zhao","year":"2018","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib71","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2009.01.013","article-title":"Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling","volume":"33","author":"Stehmeier","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biochi.2026.01.007_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.semcdb.2021.11.007","article-title":"SUMO-SIM interactions: from structure to biological functions","volume":"132","author":"Lascorz","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.biochi.2026.01.007_bib73","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/s41388-021-01704-w","article-title":"The RanBP2\/RanGAP1-SUMO complex gates \u03b2-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis","volume":"40","author":"Blondel-Tepaz","year":"2021","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.biochi.2026.01.007_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41419-024-06859-4","article-title":"Correction: NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation","volume":"15","author":"Hu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/protein\/gzu004","article-title":"Engineering pre-SUMO4 as efficient substrate of SENP2","volume":"27","author":"Liu","year":"2014","journal-title":"Protein Eng. Des. Sel."},{"issue":"9","key":"10.1016\/j.biochi.2026.01.007_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092059","article-title":"SENP proteases as potential targets for cancer therapy","volume":"13","author":"Tokarz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biochi.2026.01.007_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21775\/cimb.035.017","article-title":"Progress in the discovery of small molecule modulators of DeSUMOylation","volume":"35","author":"Chen","year":"2020","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.biochi.2026.01.007_bib78","article-title":"Emerging role of SENP1 in tumorigenesis and cancer therapy","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib79","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/biof.2055","article-title":"SUMO-specific proteases: SENPs in oxidative stress-related signaling and diseases","volume":"50","author":"Jiao","year":"2024","journal-title":"Biofactors"},{"key":"10.1016\/j.biochi.2026.01.007_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biochi.2018.06.007","article-title":"SUMO1\/sentrin\/SMT3 specific peptidase 2 modulates target molecules and its corresponding functions","volume":"152","author":"Liu","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2026.01.007_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.558220","article-title":"The critical roles of the SUMO-specific protease SENP3 in human diseases and clinical implications","volume":"11","author":"Long","year":"2020","journal-title":"Front. Physiol."},{"issue":"23","key":"10.1016\/j.biochi.2026.01.007_bib82","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1074\/jbc.M511658200","article-title":"Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3","volume":"281","author":"Gong","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib83","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1038\/s41467-019-11773-x","article-title":"The poly-SUMO2\/3 protease SENP6 enables assembly of the constitutive centromere-associated network by group deSUMOylation","volume":"10","author":"Liebelt","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/BJ20090246","article-title":"Characterization of SENP7, a SUMO-2\/3-specific isopeptidase","volume":"421","author":"Shen","year":"2009","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib85","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","article-title":"Targeting SUMO signaling to wrestle cancer","volume":"7","author":"Kroonen","year":"2021","journal-title":"Trends Cancer"},{"issue":"7","key":"10.1016\/j.biochi.2026.01.007_bib86","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13059-014-0422-2","article-title":"SUMO-specific proteases\/isopeptidases: SENPs and beyond","volume":"15","author":"Nayak","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.biochi.2026.01.007_bib87","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.biochem.73.011303.074118","article-title":"Protein modification by SUMO","volume":"73","author":"Johnson","year":"2004","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib88","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/stem.1600","article-title":"The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency","volume":"32","author":"Tahmasebi","year":"2014","journal-title":"Stem Cell."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib89","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1042\/BST20230862","article-title":"SUMO and the DNA damage response","volume":"52","author":"Bhachoo","year":"2024","journal-title":"Biochem. Soc. Trans."},{"issue":"7","key":"10.1016\/j.biochi.2026.01.007_bib90","first-page":"524","article-title":"[Hypoxia increases chemotherapy resistance in nasopharyngeal carcinoma via inducing CDK6 deSUMOylation]","volume":"54","author":"Ren","year":"2019","journal-title":"Zhonghua er bi yan hou tou jing wai ke za zhi"},{"issue":"10","key":"10.1016\/j.biochi.2026.01.007_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167419","article-title":"RNF4 sustains Myc-driven tumorigenesis by facilitating DNA replication","volume":"134","author":"Her","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib92","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7150\/thno.79688","article-title":"Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib93","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41392-020-0137-7","article-title":"NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"18","key":"10.1016\/j.biochi.2026.01.007_bib94","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138117","article-title":"ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents","volume":"5","author":"Lan","year":"2020","journal-title":"JCI Insight"},{"issue":"52","key":"10.1016\/j.biochi.2026.01.007_bib95","doi-asserted-by":"crossref","first-page":"43720","DOI":"10.1074\/jbc.M112.418053","article-title":"A novel role of Kr\u00fcppel-like factor 8 in DNA repair in breast cancer cells","volume":"287","author":"Lu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib96","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/biof.1984","article-title":"SUMO2\/3 promotes the progression and oxaliplatin resistance of colorectal cancer through facilitating the SUMOylation at Ku80-K307","volume":"49","author":"Feng","year":"2023","journal-title":"Biofactors"},{"key":"10.1016\/j.biochi.2026.01.007_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100926","article-title":"FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis","volume":"67","author":"Li","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"17","key":"10.1016\/j.biochi.2026.01.007_bib98","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-22-4017","article-title":"SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in Colon cancer","volume":"83","author":"Wei","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2026.01.007_bib103","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/ncomms5234","article-title":"SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression","volume":"5","author":"Bellail","year":"2014","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib106","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mc.23518","article-title":"Knockdown of UBE2I inhibits tumorigenesis and enhances chemosensitivity of cholangiocarcinoma via modulating p27kip1 nuclear export","volume":"62","author":"Huang","year":"2023","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib108","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12964-023-01217-x","article-title":"SUMOylation of AnxA6 facilitates EGFR-PKC\u03b1 complex formation to suppress epithelial cancer growth","volume":"21","author":"Sheng","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"7850","key":"10.1016\/j.biochi.2026.01.007_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03379-5","article-title":"Publisher correction: chromothripsis drives the evolution of gene amplification in cancer","volume":"591","author":"Shoshani","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib113","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2323768","article-title":"Repression of the SUMO-conjugating enzyme UBC9 is associated with lowered double minutes and reduced tumor progression","volume":"25","author":"Wang","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"13","key":"10.1016\/j.biochi.2026.01.007_bib114","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1093\/nar\/gkae487","article-title":"KDM6A-SND1 interaction maintains genomic stability by protecting the nascent DNA and contributes to cancer chemoresistance","volume":"52","author":"Wu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13046-021-02226-9","article-title":"SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma","volume":"41","author":"Du","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib116","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41417-022-00450-9","article-title":"SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide","volume":"30","author":"Du","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib117","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185149","article-title":"KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer","volume":"135","author":"Yu","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib118","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/s41467-024-50498-4","article-title":"Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization","volume":"15","author":"Kaito","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib120","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41418-023-01228-8","article-title":"USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A","volume":"30","author":"Mu","year":"2023","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib121","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41418-023-01139-8","article-title":"Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RAR\u03b1","volume":"30","author":"Dai","year":"2023","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib122","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12915-020-0764-z","article-title":"DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-\u03baB and sensitize to alkylating chemotherapy","volume":"18","author":"Szymura","year":"2020","journal-title":"BMC Biol."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib123","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41598-020-57698-0","article-title":"Silencing of SENP2 in multiple myeloma induces Bortezomib resistance by activating NF-\u03baB through the modulation of I\u03baB\u03b1 sumoylation","volume":"10","author":"Xie","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2026.01.007_bib124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2019.03.051","article-title":"SENP2 suppresses NF-\u03baB activation and sensitizes breast cancer cells to doxorubicin","volume":"854","author":"Gao","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biochi.2026.01.007_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101136","article-title":"CBX4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation","volume":"77","author":"Gu","year":"2024","journal-title":"Drug Resist. Updates"},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib129","doi-asserted-by":"crossref","first-page":"12447","DOI":"10.1096\/fj.201901091R","article-title":"PML hyposumoylation is responsible for the resistance of pancreatic cancer","volume":"33","author":"Swayden","year":"2019","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib130","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s13402-022-00722-4","article-title":"Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition","volume":"45","author":"Huang","year":"2022","journal-title":"Cell. Oncol."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib131","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3892\/ol.2023.13976","article-title":"miR-122\/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt\/\u03b2-catenin signaling","volume":"26","author":"Dai","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biochi.2026.01.007_bib134","article-title":"Dysregulated gene expression of SUMO machinery components induces the resistance to anti-PD-1 immunotherapy in lung cancer by upregulating the death of peripheral blood lymphocytes","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","article-title":"Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114148","article-title":"UBA5 inhibition restricts lung adenocarcinoma via blocking macrophage M2 polarization and cisplatin resistance","volume":"440","author":"Xu","year":"2024","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib137","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","article-title":"SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis","volume":"12","author":"Shangguan","year":"2021","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.biochi.2026.01.007_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158282","article-title":"Dysregulation of SIRT3 SUMOylation confers AML chemoresistance via controlling HES1-Dependent fatty acid oxidation","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2026.01.007_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216587","article-title":"USP7-mediated ER\u03b2 stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma","volume":"582","author":"Meng","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib99","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biochi.2026.01.007_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1459057","article-title":"Cell cycle checkpoint revolution: targeted therapies in the fight against malignant tumors","volume":"15","author":"Song","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biochi.2026.01.007_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101161","article-title":"Fasting-mimicking diet potentiates anti-tumor effects of CDK4\/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling","volume":"78","author":"Li","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib102","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2016.08.051","article-title":"Inhibition of CDK1 activity by sumoylation","volume":"478","author":"Xiao","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.biochi.2026.01.007_bib104","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/onc.2011.286","article-title":"New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization","volume":"31","author":"Indovina","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113295","article-title":"RNF4 promotes tumorigenesis, therapy resistance of cholangiocarcinoma and affects cell cycle by regulating the ubiquitination degradation of p27kip1 in the nucleus","volume":"419","author":"Huang","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.biochi.2026.01.007_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biochi.2026.01.007_bib109","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","article-title":"Epigenetic modifications of c-MYC: role in cancer cell reprogramming, progression and chemoresistance","volume":"83","author":"Fatma","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.biochi.2026.01.007_bib110","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/jcb.29946","article-title":"SENP1 participates in Irinotecan resistance in human colon cancer cells","volume":"122","author":"Chen","year":"2021","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib111","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc.2016.143","article-title":"SUMO and the robustness of cancer","volume":"17","author":"Seeler","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biochi.2026.01.007_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1331355","article-title":"Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours","volume":"14","author":"Bigos","year":"2024","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.biochi.2026.01.007_bib125","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","article-title":"YAP\/TAZ upstream signals and downstream responses","volume":"20","author":"Totaro","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"31","key":"10.1016\/j.biochi.2026.01.007_bib127","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103592118","article-title":"UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth","volume":"118","author":"Wolfe","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"12","key":"10.1016\/j.biochi.2026.01.007_bib128","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1039\/D3CP00227F","article-title":"The molecular mechanism of Y473 phosphorylation of UGDH relieves the inhibition effect of UDP-glucose on HuR","volume":"25","author":"Liu","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.biochi.2026.01.007_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib133","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer","volume":"22","author":"Zhuang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"7873","key":"10.1016\/j.biochi.2026.01.007_bib138","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib142","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/tpj.2009.46","article-title":"Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy","volume":"10","author":"Han","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.biochi.2026.01.007_bib143","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-015-0164-y","article-title":"Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer","volume":"8","author":"Liu","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"Supplement 1","key":"10.1016\/j.biochi.2026.01.007_bib144","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-148385","article-title":"Phase 1b\/2 study of the first-in-class SUMO-activating enzyme inhibitor TAK-981 in combination with monoclonal antibodies in patients with triple-class refractory multiple myeloma","volume":"138","author":"Lonial","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib145","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","article-title":"Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer","volume":"64","author":"Langston","year":"2021","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2018.10.026","article-title":"Allosteric inhibition of ubiquitin-like modifications by a class of inhibitor of SUMO-activating enzyme","volume":"26","author":"Li","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"18","key":"10.1016\/j.biochi.2026.01.007_bib147","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.2021014267","article-title":"The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation","volume":"139","author":"Nakamura","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib148","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/acsmedchemlett.0c00353","article-title":"Synthesis and evaluation of ginkgolic acid derivatives as SUMOylation inhibitors","volume":"11","author":"Brackett","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib149","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.chembiol.2009.01.009","article-title":"Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate","volume":"16","author":"Fukuda","year":"2009","journal-title":"Chem. Biol."},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ja.2009.10","article-title":"Kerriamycin B inhibits protein SUMOylation","volume":"62","author":"Fukuda","year":"2009","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.biochi.2026.01.007_bib151","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09003","article-title":"A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver","volume":"4","author":"Suzawa","year":"2015","journal-title":"eLife"},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib152","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ja.2013.142","article-title":"Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata","volume":"67","author":"Takemoto","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"10","key":"10.1016\/j.biochi.2026.01.007_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2021.04.014","article-title":"Targeting SUMOylation dependency in human cancer stem cells through a unique SAE2 motif revealed by chemical genomics","volume":"28","author":"Benoit","year":"2021","journal-title":"Cell Chem. Biol."},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib154","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nchembio.2463","article-title":"Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor","volume":"13","author":"He","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.biochi.2026.01.007_bib155","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/gutjnl-2018-317856","article-title":"SUMO pathway inhibition targets an aggressive pancreatic cancer subtype","volume":"69","author":"Biederst\u00e4dt","year":"2020","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217578","article-title":"Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency","volume":"14","author":"Bentz","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biochi.2026.01.007_bib157","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ja.2016.23","article-title":"Inhibition of protein SUMOylation by natural quinones","volume":"69","author":"Fukuda","year":"2016","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"12","key":"10.1016\/j.biochi.2026.01.007_bib159","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1021\/cb400630z","article-title":"Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2","volume":"8","author":"Hirohama","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.biochi.2026.01.007_bib160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10974-021-09605-x","article-title":"2-D08 treatment regulates C2C12 myoblast proliferation and differentiation via the Erk1\/2 and proteasome signaling pathways","volume":"42","author":"Liu","year":"2021","journal-title":"J. Muscle Res. Cell Motil."},{"issue":"20","key":"10.1016\/j.biochi.2026.01.007_bib161","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.2174\/0929867327666200810135039","article-title":"Current status of SUMOylation inhibitors","volume":"28","author":"Brackett","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.biochi.2026.01.007_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19336950.2021.2023383","article-title":"Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in chronic constriction injury (CCI) rats","volume":"16","author":"Li","year":"2022","journal-title":"Channels"},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib163","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/2472555216683937","article-title":"A small-molecule microarray approach for the identification of E2 enzyme inhibitors in ubiquitin-like conjugation pathways","volume":"22","author":"Zlotkowski","year":"2017","journal-title":"SLAS Discov."},{"issue":"37","key":"10.1016\/j.biochi.2026.01.007_bib164","doi-asserted-by":"crossref","first-page":"15340","DOI":"10.1074\/jbc.M117.794255","article-title":"Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation","volume":"292","author":"Wiechmann","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.biochi.2026.01.007_bib165","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1016\/j.bmcl.2011.08.101","article-title":"Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors","volume":"21","author":"Qiao","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"16","key":"10.1016\/j.biochi.2026.01.007_bib166","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1016\/j.bmcl.2012.06.084","article-title":"Discovery of 1-[4-(N-benzylamino)phenyl]-3-phenylurea derivatives as non-peptidic selective SUMO-sentrin specific protease (SENP)1 inhibitors","volume":"22","author":"Uno","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"22","key":"10.1016\/j.biochi.2026.01.007_bib167","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.bmcl.2012.09.037","article-title":"2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: virtual screening, synthesis and biological evaluation","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.biochi.2026.01.007_bib168","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejmech.2016.06.018","article-title":"Identification of SENP1 inhibitors through in silico screening and rational drug design","volume":"122","author":"Zhao","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.biochi.2026.01.007_bib169","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cmdc.202000067","article-title":"Discovery of a class of potent and selective non-competitive sentrin-specific protease 1 inhibitors","volume":"15","author":"Lindenmann","year":"2020","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037693","article-title":"Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.biochi.2026.01.007_bib171","doi-asserted-by":"crossref","first-page":"58995","DOI":"10.18632\/oncotarget.10636","article-title":"Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib172","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1021\/acs.biochem.7b00947","article-title":"Streptonigrin inhibits SENP1 and reduces the protein level of hypoxia-inducible factor 1\u03b1 (HIF1\u03b1) in cells","volume":"57","author":"Ambaye","year":"2018","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.biochi.2026.01.007_bib173","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.bmcl.2016.03.080","article-title":"Development and evaluation of a highly reliable assay for SUMO-specific protease inhibitors","volume":"26","author":"Xie","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"20","key":"10.1016\/j.biochi.2026.01.007_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012085","article-title":"Discovery of a dual SENP1 and SENP2 inhibitor","volume":"23","author":"Brand","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/ci4007134","article-title":"Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening","volume":"54","author":"Kumar","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib176","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1096\/fj.201700711R","article-title":"Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2","volume":"32","author":"Bernstock","year":"2018","journal-title":"Faseb J."},{"key":"10.1016\/j.biochi.2026.01.007_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.817990","article-title":"Identification of natural products as SENP2 inhibitors for targeted therapy in heart failure","volume":"13","author":"Taghvaei","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.biochi.2026.01.007_bib178","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1073\/pnas.1109131109","article-title":"Gold nanoparticles as a platform for creating a multivalent poly-SUMO chain inhibitor that also augments ionizing radiation","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"5","key":"10.1016\/j.biochi.2026.01.007_bib158","first-page":"1539","article-title":"miR-129-3p inhibits NHEJ pathway by targeting SAE1 and represses gastric cancer progression","volume":"12","author":"Zhang","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.biochi.2026.01.007_bib179","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900577","article-title":"Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies","volume":"3","author":"G\u00e2tel","year":"2020","journal-title":"Life Sci. Alliance"},{"issue":"4","key":"10.1016\/j.biochi.2026.01.007_bib180","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41375-023-01838-8","article-title":"Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies","volume":"37","author":"Kroonen","year":"2023","journal-title":"Leukemia"},{"issue":"6066","key":"10.1016\/j.biochi.2026.01.007_bib181","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.1212728","article-title":"A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","volume":"335","author":"Kessler","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biochi.2026.01.007_bib182","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/biom2030376","article-title":"Sumoylation and the DNA damage response","volume":"2","author":"Cremona","year":"2012","journal-title":"Biomolecules"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:53:11Z","timestamp":1773978791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908426000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":181,"alternative-id":["S0300908426000167"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.01.007","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SUMOylation and anticancer drug resistance","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}